Syndax Pharmaceuticals Inc

XNAS:SNDX

20.37

-0.04 (-0.20%)

7:35:06 PM EDT: $20.45 +0.08 (+0.39%)

Market Cap (Intraday)	1.77B
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$63.73 Million
Adjusted EPS	-$0.59

See more estimates

10-Day MA	$19.85
50-Day MA	$16.65
200-Day MA	$13.41

See more pivots

Syndax Pharmaceuticals Inc Stock, XNAS:SNDX

730 Third Avenue, floor 9, New York, New York 10017

United States of America

Phone: +1.781.419.1400

Number of Employees: 270

http://www.syndax.com

Description

Syndax Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company engaged in the development of cancer therapies. Its product candidates include SNDX-5613 and SNDX-6352. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in New York, NY.